Clinitech Laboratory Limited IPO
They operate a network of 8 diagnostic centers located in and around Thane and Navi Mumbai, providing a wide range of diagnostic and healthcare tests and services.
Their promoters bring over 30 years of experience in the diagnostic industry, ensuring high standards and expertise in our operations.
Their NABL (National Accreditation Board for Testing and Calibration Laboratories) accredited labs are equipped with modern technology and high-end equipment, allowing them to conduct more than 300,000 tests annually.
They offer over 150 different tests, categorized under the following heads:
i. Biochemistry tests
ii. Immunology tests
iii. Hematology tests
iv. Molecular Biology tests
v. Serology tests
vi. Microbiology tests
vii. Histopathology tests
Their commitment to quality and advanced diagnostic solutions positions them as a trusted provider in the healthcare industry.
Objects of the Clinitech Laboratory Limited IPO:
Clinitech Laboratory Limited IPO Details:
Open Date: | Jul 25 2024 |
Close Date: | Jul 29 2024 |
Total Shares: | 602,400 |
Face Value: | ₹ 10 Per Equity Share |
Issue Size: | 5.78 Cr. |
Lot Size: | 1200 Shares |
Issue Price: | ₹ 96 Per Equity Share |
Listing At: | BSE SME |
Listing Date: | Aug 01 2024 |
Promoters And Management:
Financials of Clinitech Laboratory Limited IPO:
Particular (In lakh) | Mar-24 | Mar-23 | Mar-22 |
Revenue from Operations | 640 | 635 | 638 |
Cost of Material Consumed | 110 | 117 | 145 |
Laboratory testing charges | 23 | 22 | 35 |
Employee Cost | 229 | 203 | 178 |
Other Expenses | 180 | 157 | 174 |
EBITDA | 98 | 136 | 106 |
EBIDTA Margin | 15.31% | 21.42% | 16.61% |
Other income | 3 | 1 | 7 |
Depreciation | 44 | 44 | 38 |
Interest | 7 | 6 | 6 |
Profit before tax | 50 | 86 | 69 |
Tax | 13 | 25 | 19 |
Net profit | 37 | 61 | 51 |
NPM (%) | 5.75% | 9.59% | 7.91% |
EPS | 1.62 | 2.67 | 2.23 |
Comparison With Peers:
Name of the Companies | Revenue (Cr) | Profit (Cr) | EPS | P/E | CMP | Mcap |
Clinitech Laboratory Limited | 6.4 | 0.37 | 1.62 | 59 | 96 | 21.9 |
Dr Lal Pathlabs Ltd. | 2227 | 362 | 42.85 | 71 | 3042 | 25394 |
Thyrocare Technologies Ltd. | 524 | 98 | 13.43 | 50 | 476 | 3952 |
Krsnaa Diagnostics Ltd. | 590 | 59 | 18.14 | 37.5 | 680 | 2197 |
Recommendation on Clinitech Laboratory Limited IPO:
Lead Manager of Clinitech Laboratory Limited IPO:
Registrar of Clinitech Laboratory Limited IPO:
Company Address:
Discussion on Clinitech Laboratory Limited IPO:
Leave a Reply
You must be logged in to post a comment.